After the merger of Gist-Brocades / Genencor and Solvay enzymes businesses, I was actively involved in the product line rationalisation as worldwide responsible manager for the so-called non-industrial enzyme markets.
I succeeded to reduce the number of products (SKU’s) by 95% and unfortunately loosing 20% of the turnover. However the overall product line profits were substantially increased with this effort. The critical balance was obvisouly to continue to satisfy customers (and our own salesteam) by offering them lead-out time and testing time as well as detailed guidance for the offered alternatives. In those years I learned about and withnessed a lot of customer processes.